Functional magnetic resonance imaging in multiple sclerosis patients with fatigue before and after neurorehabilitation therapy
|
|
- Susan Walsh
- 7 years ago
- Views:
Transcription
1 Functional magnetic resonance imaging in multiple sclerosis patients with fatigue before and after neurorehabilitation therapy Poster No.: C-2496 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Neuro M. Ukmar, E. Trincia, M. Naccarato, M. Catalan, S. Mezzarobba, M. A. Cova; Trieste/IT fmri, multiple sclerosis, fatigue /ecr2010/C-2496 Any information contained in this pdf file is automatically generated from digital material submitted to EPOS by third parties in the form of scientific presentations. References to any names, marks, products, or services of third parties or hypertext links to thirdparty sites or information are provided solely as a convenience to you and do not in any way constitute or imply ECR's endorsement, sponsorship or recommendation of the third party, information, product or service. ECR is not responsible for the content of these pages and does not make any representations regarding the content or accuracy of material in this file. As per copyright regulations, any unauthorised use of the material or parts thereof as well as commercial reproduction or multiple distribution by any traditional or electronically based reproduction/publication method ist strictly prohibited. You agree to defend, indemnify, and hold ECR harmless from and against any and all claims, damages, costs, and expenses, including attorneys' fees, arising from or related to your use of these pages. Please note: Links to movies, ppt slideshows and any other multimedia files are not available in the pdf version of presentations. Page 1 of 9
2 Purpose Fatigue is a common symptom in patients with multiple sclerosis (MS), reported in over 80% of cases and associated with a high degree of disability and a reduced quality of life [1]. The pathogenesis of fatigue in MS is still unclear, but electrophysiological and neuroimaging studies recently supported a central origin. In fact, fatigue may be correlated to motor dysfunction of circuits involving the thalamus, the basal ganglia and the frontal cortex [2,3,4]. Moreover in MS patient the f-mri demonstrates an abnormal cortical and subcortical activation while performing a nmotor task, due to functionally adaptive changes as a consequence of white and gray matter [4,5,6]. Rehabilitation treatment could modify this activation [7]. According to the evidence that fatigue is the consequence of motor planning and execution dysfunction we supposed that a specific neurorehabilitation therapy could modify the cortical activation reducing the fatigue symptoms. The aim of our study was to evaluate the pattern of activation during a motor task by f-mri in patients with MS and fatigue, without motor impairment, before and after neurorehabilitation therapy. Methods and Materials In our study we enorolled 10 female patients right handed, with relapsing-remitting MS and fatigue. The mean age was years (range years) and the mean disease duration was 5 years (range 2-10 years). EDSS (Expanded Disability Status Scale) score was low (<3.5). The fatigue score was measured by Fatigue Severity Scale (FSS) and was higher than 4.5 points. Criteria for excluding patients were ongoing clinical relapse, major depression, cognitive impairment, traeatment with immunosupressive drugs, and common contraindication to MR examination. All MR examination were performed by using 1.5 T magnet: SE PD/T2 weighted and FLAIR sequences were performed in order to calculate the lesion load. The functional evaluation was performed by an EPI sequence (TR/TE=2158/ 45 msec, 25 slices, 4 mm, no gap, 160 dynamics) during the execution of a simple finger tapping task with the right hand. Page 2 of 9
3 The neurological evaluation (disability, fatigue) and the MR examination were performed before and after the neurorehabilitation therapy. This therapy lasted three months and consisted of exercises in order to modify specifically cognitive processes during movement planning and subsequently movement control. The statistical analysis concerning disability and fatigue scale was performed using non parametric Wilcoxon test. The lesion load was calculated by using the software Analyze 5. The functional data were processed using the SPM package version 2. Single subjects SPM-maps were generated (p<0.001 corrected for multiple comparisons). Then a group analysis was performed comparing activations maps of patients before and after treatment (p<0.05 corrected for multiple comparisons). The statistical analysis, concerning functional evaluation, was performed by using Student's t-test. Results After treatment, a significant decrease in fatigue scale (FSS) was detected, while no differences were detected in disability scores (tab.1). Baseline mean±sd Follow-up mean±sd p EDSS 1.63± ±0.37 ns FSS 5.56± ± TAB: 1- Clinical evaluation before and after treatment EDSS: expanded disability status scale FSS: fatigue severity scale No differences were found regarding the total lesion load (tab.2). pre post p Page 3 of 9
4 T2 Lesion load 4.24± ±4.96 ns TAB. 2: Conventional MRI: Lesion load before and after treatment The fmri analysis performed after neurorehabilitation therapy showed a reduction in activations of both bilateral sensorimotor cortex, mainly the ipsilateral one, cerebellum and thalami (p<0.05) (Fig. 1A-B) on page 5 (Fig. 2). on page 5 Fig.: Fig 1 A-B: f-mri - cortical activation before (A) and after neurorehabiliation therapy (B). After therapy there are a reduced activation mainly in the ipsilateral sensori-motor area and in the cerebellum bilaterally. References: M. Ukmar; Department of Radiology, University of Trieste, Trieste, ITALY Page 4 of 9
5 Images for this section: Fig. 1: Fig 1 A-B: f-mri - cortical activation before (A) and after neurorehabiliation therapy (B). After therapy there are a reduced activation mainly in the ipsilateral sensori-motor area and in the cerebellum bilaterally. Page 5 of 9
6 Page 6 of 9
7 Fig. 2: Fig 2: f-mri - Pre vs post treatment analysis: reduction in activation of thalami after rehabilitation treatment. Page 7 of 9
8 Conclusion Our results confirm that there is an abnormal activation during the execution of a motor task in patients with MS and fatigue. Neurorehabilitation therapy could reduce the grade of fatigue improving the quality of life of the patients by modifying cortical and subcortical activation. The fmri could be an objective tool to evaluate the efficacy of rehabilitation treatment in MS patients with fatigue. References 1) Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Clinical characteristics of fatigue in multiple sclerosis. Arch Neurol. 45: ) Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G. (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15: ) De Luca J, Genova HM, Hillary FG, Wylie G (2008) Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. Journal Neurol Sci 270: ) Tartaglia MC, Narayanan S, Arnold DL (2008) Mental fatigue alters the pattern and increase the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue. Eur J Neurol 15: Page 8 of 9
9 5) Rocca MA, Filippi M (2007) Functional MRI in multiple sclerosis. J neuroimaging 17: 36S-41S. 6) Lee M, Reddy H, Johansen-Berg H, Pendlebury S, Jenkinson M, Smith S, Palace J, Matthews PM (2000) The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neuro 47: ) Carey LM, Seitz RJ: Functional neuroimaging in stroke recovery and neurorehabilitation: conceptual issues and perspectives (2007) Int J Stroke 2: Personal Information Maja Ukmar, MD Department of Radiology University of Trieste Italy majaukmar@alice.it Page 9 of 9
OA related pain medication intake in subjects from the OAI incidence cohort - association with focal knee lesions and cartilage T2 measurements
OA related pain medication intake in subjects from the OAI incidence cohort - association with focal knee lesions and cartilage T2 measurements Poster No.: C-0007 Congress: ECR 2012 Type: Scientific Exhibit
More informationUtilization management for successful process optimization in radiology
Utilization management for successful process optimization in radiology Poster No.: C-0737 Congress: ECR 2011 Type: Scientific Paper Authors: H.-P. Busch 1, W. Frewer 1, A. van Est 2 ; 1 Trier/DE, 2 Eindhoven/NL
More informationCT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion
CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion Poster No.: E-0084 Congress: ESTI 2012 Type: Scientific Exhibit Authors: S. S. Shim, Y. Kim; Seoul/KR Keywords:
More informationDiffuse infiltration in multiple myeloma treatment response assessment with "total-spine" contrast enhanced MR imaging
Diffuse infiltration in multiple myeloma treatment response assessment with "total-spine" contrast enhanced MR imaging Poster No.: C-0276 Congress: ECR 2011 Type: Scientific Paper Authors: P. P. Arcuri,
More informationDetermination of bone age using MRI of hand/wrist: a pilot study
Determination of bone age using MRI of hand/wrist: a pilot study Poster No.: C-0963 Congress: ECR 2011 Type: Scientific Exhibit Authors: E. Tomei, M. Marini, A. Stagnitti, A. sartori, L. bertana, N. Al
More informationPatterns of nodal spread in thoracic malignancies
Patterns of nodal spread in thoracic malignancies Poster No.: C-0977 Congress: ECR 2010 Type: Educational Exhibit Topic: Chest Authors: R. dos Santos, M. Duarte, J. Alpendre, J. Castaño, Z. Seabra, Â.
More informationAn Image Based Semiautomatic Online Cancer Staging Program for Common Female Pelvic Malignancies
An Image Based Semiautomatic Online Cancer Staging Program for Common Female Pelvic Malignancies Poster No.: C-1050 Congress: ECR 2012 Type: Educational Exhibit Authors: R. Talanow; Lexington, KY/US Keywords:
More informationComparison of radiation dose from X-ray, CT, and PET/ CT in paediatric patients with neuroblastoma using a dose monitoring program
Comparison of radiation dose from X-ray, CT, and PET/ CT in paediatric patients with neuroblastoma using a dose monitoring program Poster No.: C-0591 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific
More informationPreoperative evaluation of future remnant liver function by the contrast enhance ratio in hepatocellular image.
Preoperative evaluation of future remnant liver function by the contrast enhance ratio in hepatocellular image. Poster No.: C-0564 Congress: ECR 2011 Type: Scientific Exhibit Authors: S. Matsushima, Y.
More informationEye lens dose measurements in Interventional Cardiology
Eye lens dose measurements in Interventional Cardiology Poster No.: 479 Congress: ESCR 2014 Type: Scientific Poster Authors: N. Kollaros 1, E. Carinou 2, C. Plemmenos 1, I. Stathopoulos 1, V. Keywords:
More informationMRI scanning of the claustrophobic patients
MRI scanning of the claustrophobic patients Poster No.: C-0549 Congress: ECR 2014 Type: Educational Exhibit Authors: M. minov, A. Doreski, M. Popovska, G. Markoski, S. 1 2 3 2 2 1 2 2 3 Jovanoska, I. miladinovski
More informationDevelopment and implementation of a help desk system in a radiology department in a high complexity hospital: a South American experience
Development and implementation of a help desk system in a radiology department in a high complexity hospital: a South American experience Poster No.: C-2409 Congress: ECR 2013 Type: Authors: Keywords:
More informationNeedle crystal detector technology in mammography further dose reduction and clinical image quality with
Needle crystal detector technology in mammography further dose reduction and clinical image quality with different beam qualities (W/Rh vs. Mo/Rh) Poster No.: C-1461 Congress: ECR 2013 Type: Scientific
More informationPancreatic masses: What is there besides cancer
Pancreatic masses: What is there besides cancer Poster No.: C-0201 Congress: ECR 2010 Type: Educational Exhibit Topic: Abdominal Viscera (Solid Organs) Authors: M. A. Portilha, C. Ruivo, I. Santiago, M.
More informationAcute abdominal pain in the elderly patient: Impact of early MDCT examination on diagnosis and management
Acute abdominal pain in the elderly patient: Impact of early MDCT examination on diagnosis and management Poster No.: C-1464 Congress: ECR 2010 Type: Topic: Scientific Exhibit GI Tract Authors: A. Pinto,
More informationNormal vascular variants of the upper extremity
Normal vascular variants of the upper extremity Poster No.: C-1039 Congress: ECR 2014 Type: Educational Exhibit Authors: P. Paixao, A. P. Gomes, M. S. C. Sousa, I. Santiago, A. S. C. C. Germano; Amadora/PT
More informationDICOM metadata-mining in PACS for computed radiography X-Ray exposure analysis: a mammography multisite study
DICOM metadata-mining in PACS for computed radiography X-Ray exposure analysis: a mammography multisite study Poster No.: B-0276 Congress: ECR 2014 Type: Authors: Keywords: DOI: Scientific Paper M. R.
More informationMetastatic malignant melanoma revisited
Metastatic malignant melanoma revisited Poster No.: C-2446 Congress: ECR 2010 Type: Educational Exhibit Topic: Musculoskeletal Authors: C. Paulino, B. Gonçalves, P. Marques, M. Gonçalo, F. CaseiroAlves;
More informationRole of 3D volumetry CT in the correlation between postoperative gastric volume and weight loss in obese patients undergoing gastric sleeve surgery.
Role of 3D volumetry CT in the correlation between postoperative gastric volume and weight loss in obese patients undergoing gastric sleeve surgery. Poster No.: C-2145 Congress: ECR 2014 Type: Scientific
More informationAngio-CT preoperative planning of inferior limb free flaps in plastic surgery
Angio-CT preoperative planning of inferior limb free flaps in plastic surgery Poster No.: C-3046 Congress: ECR 2010 Type: Educational Exhibit Topic: Vascular Authors: L. Saba, M. Atzeni, D. Ribuffo, G.
More informationMULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION Michael K. Racke, MD Professor and Chairman in Neurology The Helen C. Kurtz Chair in Neurology Department of Neurology Ohio State University
More informationCognitive rehabilitation in MS
14th MS Nurse International Workshop Lyon, France, October 9th 2012 Cognitive and psychological issues in MS Cognitive rehabilitation in MS Psychological Unit Neurological Department San Raffaele Hospital
More informationClinical Study Synopsis
Clinical Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website. It is provided for patients and healthcare professionals to increase the transparency of
More informationComparison between photoacoustic mammography images of breasts cancers and histological staining patterns of CD31 and carbonic anhydrase IX
Comparison between photoacoustic mammography images of breasts cancers and histological staining patterns of CD31 and carbonic anhydrase IX Poster No.: C-1893 Congress: ECR 2013 Type: Scientific Exhibit
More informationFatigue in MS: 2005 update B. Colombo University of Milan - HSR
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS One of the more disabling symptoms Affects about 75/90 % of the patients May be the onset symptom Transient or chronic May
More informationDifferential diagnosis of vertebral compression fracture using in-phase/opposed-phase and Short TI inversion recovery imaging
Differential diagnosis of vertebral compression fracture using in-phase/opposed-phase and Short TI inversion recovery imaging Poster No.: C-0795 Congress: ECR 2013 Type: Scientific Exhibit Authors: A.
More informationSecond look ultrasound examination for breast lesions: MRI and pathologic correlation
Second look ultrasound examination for breast lesions: MRI and pathologic correlation Poster No.: C-0559 Congress: ECR 2015 Type: Scientific Exhibit Authors: E. Serrano Tamayo, E. López Soriano, M. Muñoz
More informationMR imaging of primary sclerosing cholangitis (PSC) using the hepatobiliary specific contrast agent Gd-EOB-DTPA
MR imaging of primary sclerosing cholangitis (PSC) using the hepatobiliary specific contrast agent Gd-EOB-DTPA Poster No.: C-0019 Congress: ECR 2010 Type: Educational Exhibit Topic: Abdominal Viscera (Solid
More informationMontreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.
Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Suresh Kumar, M.D. AUTHOR Director of: Neurology & Headaches Center Inc. Neurocognitve &TBI Rehabilitation Center
More informationSTROKE CARE NOW NETWORK CONFERENCE MAY 22, 2014
STROKE CARE NOW NETWORK CONFERENCE MAY 22, 2014 Rehabilitation Innovations in Post- Stroke Recovery Madhav Bhat, MD Fort Wayne Neurological Center DISCLOSURE Paid speaker for TEVA Neuroscience Program.
More informationin Persons with Multiple Sclerosis]
Faculty BARBARA S. GIESSER, MD Professor of Neurology Vice Chair, Education and Clinical Affairs, Neurology David Geffen School of Medicine University of California, Los Angeles Instructor Bio Barbara
More informationVersion History. Previous Versions. Drugs for MS.Drug facts box fingolimod Version 1.0 Author
Version History Policy Title Drugs for MS.Drug facts box fingolimod Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields as required
More informationDiagnostic performance of MRI in differentiating metastatic from acute osteoporotic compression fractures of the spine
Diagnostic performance of MRI in differentiating metastatic from acute osteoporotic compression fractures of the spine Poster No.: C-1399 Congress: ECR 2013 Type: Scientific Exhibit Authors: J. Martel,
More informationRelapsing-remitting multiple sclerosis Ambulatory with or without aid
AVONEX/BETASERON/COPAXONE/EXTAVIA/GILENYA/REBIF/TYSABRI Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 5 PATIENT INFMATION Surname First Name Middle Initial Sex Date
More informationStage A & C Sample Data Collection Form
Stage A & C Sample Data Collection Form Instructions: Review a minimum of 20 patient charts (or another number determined to be appropriate) from patients most recently admitted, and complete this Data
More informationMULTIPLE SCLEROSIS AND DEPRESSION. Michael Racke, MD The Ohio State University Meera Narasimhan, MD University of South Carolina
MULTIPLE SCLEROSIS AND DEPRESSION Michael Racke, MD The Ohio State University Meera Narasimhan, MD University of South Carolina MICHAEL RACKE, MD Disclosures!! Research/Grants: National Institute of Neurologic
More informationChapter 10. Summary & Future perspectives
Summary & Future perspectives 123 Multiple sclerosis is a chronic disorder of the central nervous system, characterized by inflammation and axonal degeneration. All current therapies modulate the peripheral
More informationThalamo-striato-cortical determinants to fatigue in multiple sclerosis
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis Maria Engström, Gullvi Flensner, Anne-Marie Landtblom, Anna-Christina Ek and Thomas Karlsson Linköping University Post Print N.B.:
More informationClinical Study Treatment of Fatigue in Multiple Sclerosis Patients: A Neurocognitive Approach
Rehabilitation Research and Practice Volume 2011, Article ID 670537, 5 pages doi:10.1155/2011/670537 Clinical Study Treatment of Fatigue in Multiple Sclerosis Patients: A Neurocognitive Approach Mauro
More informationOptimization of treatment with interferon beta in multiple sclerosis. Usefulness of automatic system application criteria
Optimization of treatment with interferon beta in multiple sclerosis. Usefulness of automatic system application criteria AUTHORS Juan Luis Ruiz-Peña, Pablo Duque, and Guillermo Izquierdo Address: Unidad
More informationSummary chapter 2 chapter 2
Summary Multiple Sclerosis (MS) is a chronic disease of the brain and the spinal cord. The cause of MS is unknown. MS usually starts in young adulthood. In the course of the disease progression of neurological
More informationVersion History. Previous Versions. Policy Title. Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author
Version History Policy Title Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields
More informationCognitive Neuroscience. Questions. Multiple Methods. Electrophysiology. Multiple Methods. Approaches to Thinking about the Mind
Cognitive Neuroscience Approaches to Thinking about the Mind Cognitive Neuroscience Evolutionary Approach Sept 20-22, 2004 Interdisciplinary approach Rapidly changing How does the brain enable cognition?
More information2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives
Descriptions and Neuroplasticity Health care providers are facing greater time restrictions to render services to the individual with neurological dysfunction. However, the scientific community has recognized
More informationß-interferon and. ABN Guidelines for 2007 Treatment of Multiple Sclerosis with. Glatiramer Acetate
ABN Guidelines for 2007 Treatment of Multiple Sclerosis with ß-interferon and Glatiramer Acetate Published by the Association of British Neurologists Ormond House, 27 Boswell Street, London WC1N 3JZ Contents
More informationMemory Development and Frontal Lobe Insult
University Press Scholarship Online You are looking at 1-10 of 11 items for: keywords : traumatic brain injury Memory Development and Frontal Lobe Insult Gerri Hanten and Harvey S. Levin in Origins and
More informationCalendar of events NEUROLOGY
Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the
More informationNEURO M203 & BIOMED M263 WINTER 2014
NEURO M203 & BIOMED M263 WINTER 2014 MRI Lab 1: Structural and Functional Anatomy During today s lab, you will work with and view the structural and functional imaging data collected from the scanning
More informationSummary HTA. Interferons and Natalizumab for Multiple Sclerosis Clar C, Velasco-Garrido M, Gericke C. HTA-Report Summary
Summary HTA HTA-Report Summary Interferons and Natalizumab for Multiple Sclerosis Clar C, Velasco-Garrido M, Gericke C Health policy background Multiple sclerosis (MS) is a chronic inflammatory disease
More informationReversibility of Acute Demyelinating Lesions in relapsingremitting
Reversibility of Acute Demyelinating Lesions in relapsingremitting Multiple Sclerosis Omar A. Khan ( Division of Neuroimmunology, Department of Neurology, Neurology and Research Services. Veterans Affairs
More informationCollege of Health and Human Services Department of Physical Therapy
College of Health and Human Services Department of Physical Therapy Neurological Evaluation & Treatment II (PT244) Fall Semester 2009 COURSE CREDIT: 4 units: 2 hours lecture, 6 hours of lab per week CLASSROOM:
More informationHow To Use A Drug In Multiple Sclerosis
Revised (2009) guidelines for prescribing in multiple sclerosis INTRODUCTION In January 2001, the (ABN) first published guidelines for the use of licensed disease modifying treatments (ß-interferon and
More informationPrimary Motor Pathway
Understanding Eye Movements Abdullah Moh. El-Menaisy, MD, FRCS Chief, Neuro-ophthalmology ophthalmology & Investigation Units, Dhahran Eye Specialist Hospital, Dhahran, Saudi Arabia Primary Motor Pathway
More informationFUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov
FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative
More informationPROFESSIONAL EXPERIENCE
CURRICULUM VITAE Catherine F. H. Siengsukon Office Phone: 913-588-6913 Mail Stop 2002 Lab Phone: 913-588-0601 3901 Rainbow Blvd Fax: 913-588-4568 Kansas City, KS 66160 Email: csiengsukon@kumc.edu Physical
More informationAbdominal CT Perfusion: Effects of Breath Control Technique
Abdominal CT Perfusion: Effects of Breath Control Technique Poster No.: C-0068 Congress: ECR 2014 Type: Scientific Exhibit Authors: T. Yoshikawa, T. Kanda, Y. Ohno, Y. Fujisawa, N. Negi, M. 1 1 2 1 1 1
More informationWhole-brain Functional MR Imaging Activation from a Finger-tapping Task Examined with Independent Component Analysis
AJNR Am J Neuroradiol 21:1629 1635, October 2000 Whole-brain Functional MR Imaging Activation from a Finger-tapping Task Examined with Independent Component Analysis Chad H. Moritz, Victor M. Haughton,
More informationMellen Center for Multiple Sclerosis
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Gold R, Giovannoni G, Selmaj K, et al, for
More informationThe Use of the Lokomat System in Clinical Research
International Neurorehabilitation Symposium February 12, 2009 The Use of the Lokomat System in Clinical Research Keith Tansey, MD, PhD Director, Spinal Cord Injury Research Crawford Research Institute,
More informationImaging Markers of Brain Network Dysfunction in Multiple Sclerosis
Faculty of Medicine & Health Sciences School of Medicine Radiological Sciences Research Group The University of Nottinham University Park Nottingham NG7 2RD t: +44 (0)115 823 0018 f: +44 (0)115 823 0004
More informationBy Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH
By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH Main Sources of Federal Funding for Cerebral Palsy and Disability
More informationMagnetic Resonance Techniques in Multiple Sclerosis
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita - Salute San Raffaele University
More information1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)
UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:
More informationMeasurement Issues in Short Term Clinical Trials. Brian Healy, PhD
Measurement Issues in Short Term Clinical Trials Brian Healy, PhD Overview n In order to iden>fy treatment effects or predictors of disease course, measurement of disease course is required n Although
More informationObtaining Knowledge. Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology.
Lecture 7 Methods of Scientific Observation and Analysis in Behavioral Psychology and Neuropsychology 1.Obtaining Knowledge 1. Correlation 2. Causation 2.Hypothesis Generation & Measures 3.Looking into
More informationPCORI Workshop on Treatment for Multiple Sclerosis. Breakout Group Topics and Questions Draft 3-27-15
PCORI Workshop on Treatment for Multiple Sclerosis Breakout Group Topics and Questions Draft 3-27-15 Group 1 - Comparison across DMTs, including differential effects in subgroups Consolidated straw man
More informationAdolescent Brain Development and Effects of Alcohol Use
Adolescent Brain Development and Effects of Alcohol Use Monica Luciana, Ph.D. Professor and Chair Department of Psychology and Center for Neurobehavioral Development University of Minnesota (lucia003@umn.edu)
More informationNeuro-rehabilitation in Stroke. Amit Kumar Neuro-Occupational Therapist
Neuro-rehabilitation in Stroke Amit Kumar Neuro-Occupational Therapist Neuro-rehabilitation A process whereby patients who suffer from impairment following neurologic diseases regain their former abilities
More informationSupplementary Online Content
Supplementary Online Content Burt RK, Balabanov R, Han X, et al. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting
More informationRational basis for early treatment in MS. Bonaventura Casanova Estruch Unitat d Esclerosi Múltiple Hospital Universitari la Fe València
Rational basis for early treatment in MS Bonaventura Casanova Estruch Unitat d Esclerosi Múltiple Hospital Universitari la Fe València Bonaventura Casanova Department of Neurology University Hospital La
More informationMRI in Differential Diagnosis
MRI in Differential Diagnosis Jill Conway, MD, MA, MSCE Director, Carolinas MS Center Clerkship Director, UNCSOM-Charlotte Campus Charlotte, NC DISCLOSURES Speaking, consulting, and/or advisory boards
More informationAnoxic Brain Injury and Neural Damage: Three Case Reports
Anoxic Brain Injury and Neural Damage: Three Case Reports Abstract Anoxic brain injury (ABI) is common and can occur in a wide variety of disorders. This neural injury is associated with significant and
More informationClinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets
494 J Neurol Neurosurg Psychiatry 21;7:494 499 Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets M P Sormani, D H Miller, G Comi,
More informationPrior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
More informationCognitive Rehabilitation of Blast Traumatic Brain Injury
Cognitive Rehabilitation of Blast Traumatic Brain Injury Yelena Bogdanova, PhD VA Boston Healthcare System Rehabilitation Research & Development Boston University School of Medicine IOM Committee on Cognitive
More informationClinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December 2012. Reference : NHSCB/D4/c/1
Clinical Commissioning Policy: Disease Modifying Therapies For patients With Multiple Sclerosis (MS) December 2012 Reference : NHSCB/D4/c/1 NHS Commissioning Board Clinical Commissioning Policy: Disease
More informationExercise therapy and multiple sclerosis a powerful non-pharmacological intervention
Malmö, November 2014 Exercise therapy and multiple sclerosis a powerful non-pharmacological intervention Ulrik Dalgas, PhD Department of Public Health Section of Sport Science Aarhus University Denmark
More informationClinical Neuropsychology. Recovery & Rehabilitation. Alan Sunderland School of Psychology
Clinical Neuropsychology. Recovery & Rehabilitation Alan Sunderland School of Psychology 1 The Changing Role of Clinical Neuropsychology HISTORY The Origins of Clinical Neuropsychology Emergence as a profession
More informationPrior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
More informationPRO BALLOON VENOPLASTY IS A PROMISING TECHNOLOGY FOR TREATMENT OF MS
PRO BALLOON VENOPLASTY IS A PROMISING TECHNOLOGY FOR TREATMENT OF MS Manish Mehta MD MPH The Vascular Group The Institute for Vascular Health & Disease Albany Medical Center SVS 2012 DISCLOSURES Research,
More informationEffect of BEMER Magnetic Field Therapy on the Level of Fatigue in Patients with Multiple Sclerosis: A Randomized, Double-Blind Controlled Trial
THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 15, Number 5, 2009, pp. 507 511 ª Mary Ann Liebert, Inc. DOI: 10.1089=acm.2008.0501 Effect of BEMER Magnetic Field Therapy on the Level of Fatigue
More informationDisease Modifying Therapies (DMTs) in Multiple Sclerosis
Disease Modifying Therapies (DMTs) in Multiple Sclerosis Gary Stobbe, MD Medical Director, MS Project ECHO Clinical Assistant Professor, UW Neurology Conflict of Interest Dr. Stobbe has no conflicts of
More informationMellen Center Approaches: Identifying and managing cognitive disorders in MS
Mellen Center Approaches: Identifying and managing cognitive disorders in MS Framework: Cognitive dysfunction is common in the MS population. It affects quality of life and correlates with worsened disease
More informationWhat is Multiple Sclerosis? Gener al information
What is Multiple Sclerosis? Gener al information Kim, diagnosed in 1986 What is MS? Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (brain and spinal
More informationRehabilitation and the role of carers
Rehabilitation and the role of carers Dr Jacinta Morgan Consultant in Rehabilitation Medicine National Clinical Lead, Rehabilitation Medicine Programme (HSE CSPD) EMSP Spring Conference Gibson Hotel Dublin,
More informationProgress in MS: Current and Emerging Therapies
Progress in MS: Current and Emerging Therapies Presented by: Dr. Kathryn Giles, MD MSc FRCPC The MS Society gratefully acknowledges the grant received from Biogen Idec Canada, which makes possible the
More informationA Rapidly Growing Population with. - Murray Goldstein, DO, MPH Chairman, Cerebral Palsy International Research CPIRF
Adults with Cerebral Palsy A Rapidly Growing Population with Complex Health Issues - Murray Goldstein, DO, MPH Chairman, Cerebral Palsy International Research Foundation Scientific Advisory Council CPIRF
More informationMultiple Sclerosis: An imaging review and update on new treatments.
Multiple Sclerosis: An imaging review and update on new treatments. Dr Marcus Likeman Consultant Neuroradiologist North Bristol NHS Trust Bristol Royal Hospital for Children MRI appearances - White Matter
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Giovannoni G, Gold R, Selmaj K, et al,
More information06/06/2012. The Impact of Multiple Sclerosis in the Pacific Northwest. James Bowen, MD. Swedish Neuroscience Institute
The Impact of Multiple Sclerosis in the Pacific Northwest James Bowen, MD Multiple Sclerosis Center Multiple Sclerosis Center Swedish Neuroscience Institute 1 2 Motor Symptoms of MS Weakness Spasticity
More informationSerial Contrast-Enhanced MR in Patients with Multiple Sclerosis and Varying Levels of Disability
Serial Contrast-Enhanced MR in Patients with Multiple Sclerosis and Varying Levels of Disability Massimo Filippi, Paolo Rossi, Adriana Campi, Bruno Colombo, Clodoaldo Pereira, and Giancarlo Comi PURPOSE:
More informationOHTAC Recommendation
OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the
More informationKimberly Anderson-Erisman, PhD Director of Education University of Miami & Miami Project to Cure Paralysis
Webinar title: What is the Vibe? Vibration Therapy as a Rehabilitation Tool Presenter/presenters: Kimberly Anderson-Erisman, PhD Director of Education University of Miami & Miami Project to Cure Paralysis
More informationAdvances in the Use of MRI in the Management of MS. The Role of MRI in MS Management. Jack H. Simon Portland, Oregon
Advances in the Use of MRI in the Management of MS The Role of MRI in MS Management Jack H. Simon Portland, Oregon Disclosures Dr. Simon has nothing to disclose. This continuing education activity is managed
More informationCritical Review: Sarah Rentz M.Cl.Sc (SLP) Candidate University of Western Ontario: School of Communication Sciences and Disorders
Critical Review: In children with cerebral palsy and a diagnosis of dysarthria, what is the effectiveness of speech interventions on improving speech intelligibility? Sarah Rentz M.Cl.Sc (SLP) Candidate
More informationAttention & Memory Deficits in TBI Patients. An Overview
Attention & Memory Deficits in TBI Patients An Overview References Chan, R., et.al.. (2003). Are there sub-types of attentional deficits in patients with persisting post- concussive symptoms? A cluster
More informationChild & Adolescent Anxiety: Psychopathology and Neuroscience
bbrfoundation.org Child & Adolescent Anxiety: Psychopathology and Neuroscience Daniel S. Pine, M.D. Chief, Child & Adolescent Research Mood & Anxiety Disorders Program National Institute of Mental Health
More informationVAGUS NERVE STIMULATION FOR PATIENTS IN RESIDENTIAL TREATMENT FACILITIES
VAGUS NERVE STIMULATION FOR PATIENTS IN RESIDENTIAL TREATMENT FACILITIES Michael Frost, MD Roger Huf, MD John Gates, MD This paper has been prepared specifically for: American Epilepsy Society Annual Meeting
More informationPSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING
Status Active Medical and Behavioral Health Policy Section: Behavioral Health Policy Number: X-45 Effective Date: 01/22/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members
More information